medigraphic.com
SPANISH

Anales de Otorrinolaringología Mexicana

Anales de Otorrinolaringología Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Otorrinolaringología 2025; 70 (2)

Application of collagenase in patients with hypertrophic scarring following rhinoplasty

Escalante BK, Durán OM, Pineda CF, Sotelo RMT
Full text How to cite this article

Language: Spanish
References: 12
Page: 81-89
PDF size: 307.49 Kb.


Key words:

Collagenase, Hypertrophic scars, Rhinoseptoplasty, Nasal obstruction.

ABSTRACT

Objective: To evaluate the effectiveness of intralesional collagenase in improving hypertrophic nasal scars, focusing on aesthetics and functionality.
Materials and Methods: Quasi-experimental intersubject pre-posttest design including patients with hypertrophic scars post-rhinoseptoplasty that were classified by scar age: 0-6 months, 7-12 months, and over 12 months. Intralesional collagenase was applied using the blanching technique. Changes in pigmentation, vascularity, and thickness were evaluated using the Vancouver scale, and nasal obstruction was assessed using the NOSE scale, both pre- and post-treatment.
Results: Thirteen patients were included. Recent scars (0-6 months) showed the greatest reductions in pigmentation (7.7%) and thickness (8.2%). Medium-aged scars (7-12 months) had the largest decreases in vascularity (17.8%) and NOSE score improvement (10.8%). Older scars (over 12 months) demonstrated less response, with reductions in pigmentation (5%) and thickness (5.2%).
Conclusions: Intralesional collagenase effectively improves aesthetics and functionality in recent and medium-aged scars, with a reduced impact on older scars. This treatment offers a viable non-surgical alternative for post-rhinoseptoplasty complications.


REFERENCES

  1. Moretti EA. Experiencia en el tratamiento del colapso de la válvula nasal con injerto de cartílago de conchaauricular. Cir Plast Ibero-Latinoam 2014; 40 (3): 299-306. https://doi.org/10.4321/S0376-78922014000300008

  2. Tardy ME, Thomas JR, Sclafani AP. (2015). Rhinoplasty. In: Cummings Otolaryngology. 6th ed. Elsevier,2021. 10.1016/B978-1-4557-4696-5.00034-8

  3. Kahveci OK, Miman MC, Yucel A, Yucedag F, et al. The efficiency of Nose Obstruction Symptom Evaluation(NOSE) scale on patients with nasal septal deviation. Auris Nasus Larynx 2012; 39 (3): 275-9. https://doi.org/10.1016/j.anl.2011.08.006

  4. Rao N, Toriumi DM. Principles of rhinoplasty. In: Aesthetic Surgery of the Facial Skeleton. Elsevier,2022: 291-98.

  5. Rivera PZ. Uso de enzimas como tratamiento dermatológico regenerador de las líneas de expresión. Revistade Salud Vive 2020; 3 (8): 77-84.

  6. de Castro GMP, Muñoz MJR. Multicenter clinical study to evaluate the efficacy and safety of hyaluronicacid and enzyme cocktail in scars. Dermatol CMQ 2020; 18 (2): 84-92.

  7. Van Wart HE. Clostridium collagenases. In: Handbook of Proteolytic Enzymes. 3rd ed. Academic Press,2013: 607-11.

  8. Barbieri L Giachero V. Colapso valvular nasal. Arquivos Catarinenses Medicina 2015; 44 (Supl 1): 8-11.

  9. Shahrokh C Husain A. Functional and cosmetic rhinoplasty. In: Clinical review of oral and maxillofacialsurgery. Elsevier, 2014: 411-55.

  10. Winkler AA MD. ENT Secrets. Functional and Cosmetic Rhinoplasty. Elsevier, 2023.

  11. Buchanan EP, Monson LA, Edward II P. Secondary deformities of the cleft lip palate and nose. In: PlasticSurgery. Elsevier, 2018: 621-36.

  12. Highlights of Prescribing Information. QWO collagenase clostridium histolyticum-aaes for injection.FDA 2020.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Otorrinolaringología. 2025;70